
RG7916 moves to pivotal clinical trial in SMA types 2 and 3
Exciting developments! Roche’s new experimental drug for SMA is moving to late-phase clinical trial in SMA types 2 and 3.
UK campaign for access to treatments and support for those with spinal muscular atrophy
Exciting developments! Roche’s new experimental drug for SMA is moving to late-phase clinical trial in SMA types 2 and 3.
Exciting developments! Roche’s new experimental drug for SMA is moving to late-phase clinical trial in SMA types 2 and 3.
Come and join our meetup on Monday 18 September to talk about access to SMA treatments and what we all need to do to receive it.
Come and join our meetup on Monday 18 September to talk about access to SMA treatments and what we all need to do to receive it.